Therapy Areas: Diabetes
18 March 2019 - United States-based Xeris Pharmaceuticals has started dosing patients in a phase two trial with its ready-to-use, room-temperature stable liquid glucagon in patients with Type one diab...
15 March 2019 - - US-based specialty pharmaceutical company Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) has now begun dosing patients in a Phase 2 trial with its ready-to-use, room-temperature stable l...
15 March 2019 - - A Data Safety Monitoring Board has recommended the continuation of US-based biopharmaceutical company Soleno Therapeutics, Inc.'s (NASDAQ: SLNO) Phase III trial in Prader-Willi ...
12 March 2019 - Genmab A/S (CPH: GEN) announced on Monday the appointment of Marisol Peron as corporate vice president, Communications and Investor Relations, effective 11 March 2019.In her new role, ...
11 March 2019 - - US-based nonclinical services provider Sinclair Research and US-based nonclinical hearing research specialist Turner Scientific have formed an exclusive partnership to offer GLP...
11 March 2019 - - US-based Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) has dosed the first subjects in a Phase 1 clinical study of ARO-APOC3, an RNAi-based investigational medicine targeting Apolipo...
Related Headlines